Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy (Q45411729)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2006
edit
Language Label Description Also known as
English
Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy
scientific article published in October 2006

    Statements

    Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy (English)
    Mark J Abzug
    Lin-Ye Song
    Terence Fenton
    Myron J Levin
    William Borkowsky
    Howard M Rosenblatt
    John F Marcinak
    Arry Dieudonne
    Indu Pathak
    Pediatric AIDS Clinical Trials Group P1024 Protocol Team
    1 October 2006
    920-929

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit